Dr. Daniel Paul Sherbet, MD

Dr. Sherbet practices at Arkansas Heart Hospital in Little Rock, Arkansas, part of Arkansas Heart Hospital.

Dr. Sherbet's NPI, 1558572552, was assigned on May 24, 2007. Dr. Sherbet graduated from University of Texas Southwestern Medical School at Dallas in 2006. Dr. Sherbet holds Arkansas license E-8380.

Dr. Sherbet's primary practice is Arkansas Heart Hospital, at 1701 S Shackleford Road, Little Rock, AR 72211 in Pulaski County. The practice phone is (501) 219-7000.

Dr. Sherbet's primary practice is Arkansas Heart Hospital in Little Rock, Arkansas, part of Arkansas Heart Hospital. Dr. Sherbet is also affiliated with Oklahoma Heart Hospital North. The medical group on file is Arkansas Heart Hospital Clinic (Little Rock Clinic). Dmand AI also links Dr. Sherbet to 2 more hospitals, 4 medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sherbet practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Sherbet's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Sherbet is licensed in Arkansas.

CMS data shows 5,739 Medicare services from Dr. Sherbet across 31 procedure codes in 2024, for 1,966 Medicare patients. Medicare paid $348,648 for them.

CMS counts 1,966 Medicare patients who saw Dr. Sherbet in 2024. The largest group is 65 to 74, with 925 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.19, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Sherbet's median patient age at 73, with 49% women.

In 2024, Dr. Sherbet wrote 9,714 Medicare Part D claims for 1,385 patients. 88% of them were for generic drugs. CMS names the drug for 9,523 of them, across 68 drugs with 11 or more claims each, at $998,981 in total drug cost. In 2023, CMS named 8,803 claims across 62 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Sherbet for performance year 2024, reported as part of a group. Dr. Sherbet accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 32 procedures of coronary angioplasty and stenting by Dr. Sherbet, more than 68% of the clinicians it reports for that procedure.

Leg revascularization (restoring blood flow): 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Sherbet, published from 2012 to 2016. The most frequent topics are Coronary Angiography and Coronary Occlusion. Dr. Sherbet has published most often in J Invasive Cardiol. Dr. Sherbet's most frequent co-authors are Subhash Banerjee, MD, Jeffrey Hastings, MD, MS and Shuaib Abdullah, MD.

Dmand AI links Dr. Sherbet to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Coronary Artery Disease and Coronary Disease.

CMS Open Payments shows 186 general payments to Dr. Sherbet from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Abbott Laboratories paid the most, $6,498. It also lists 5 research payments totaling $319 in 2023.

Dr. Sherbet graduated from University of Texas Southwestern Medical School at Dallas in 2006.